700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02427

Synthetic patientMETA-24 · Day 174 · 65–74 · F · baseline S08Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
19%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S08
  2. Day 16 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 16.

Primary contributors, last 14 days
  • Treatment adherence-7
  • Inflammatory activity-3
  • Toxicity+3
  • GI instability+2
  • Nutritional resilience+2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    33 min
    worsening · -2.4 vs previous 14 d
    Sleep duration
    Wearable
    7.6 h
    worsening · -0.4 vs previous 14 d
    Energy level
    Daily log
    6.3/10
    worsening · -0.3 vs previous 14 d
    Steps
    Wearable
    3,125
    worsening · -508 vs previous 14 d
    GI burden
    Companion
    21.1/100
    worsening · +5.7 vs previous 14 d
    Adherence
    Companion
    90.4 %
    stable · +2.6 vs previous 14 d
    Sleep quality
    Wearable
    59.4/100
    worsening · -8.1 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    120 mg/dL
    stable · +2.9 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 74 from the failing basin, 17 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +10.4
    • Butyrate producers intact
      hidden · steering +7.5
    • Alcohol (supports)
      perturbation · steering +5
    • Protein
      supporter · GI -5.7 next day
    • Alcohol
      supporter · GI -3.4 next day
    Main detractors to watch
    • Bacteroides fragilis elevated
      hidden · steering -7.4
    • Poor-sleep week
      perturbation · steering -3
    • Dietary drift
      perturbation · steering -2.6
    • Alcohol on dosing days
      perturbation · steering -1.8
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -5.7supporter · 95%
    • Alcohol
      -3.4supporter · 80%
    • Ultra-processed food
      +1.1no signal · 17%
    • Caffeine
      -0.7no signal · 15%
    • Insoluble fibre
      +0.6no signal · 15%
    • Histamine load
      +0.2no signal · 15%
    • Simple carbohydrates
      -0.2no signal · 15%
    • Dietary fat load
      0no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity ↓30
      • MicrobiomeAkkermansia low → thinner mucus layer
    • Inflammatory signalling ↓20
      • MicrobiomeBacteroides fragilis expansion
    • Autonomic recovery ↓20
      • Wearable3,125 steps/day
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 4.4 · butyrate capacity 46/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    44 ms
    Sleep
    7.3 h
    Steps
    3,595
    Resting HR
    68 bpm
    Daily log: GI score 21, nutritional resilience 67, adherence 90.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0256849%S01——51
    P-0255048%S01——70
    P-0243746%S01——64
    P-0221745%S01——61
    P-0227644%S01——57
    P-0242444%S01——62
    P-0259844%S01——53
    P-0262044%S01HY-01improved64
    P-0230742%S01——55
    P-0268141%S01——51
    P-0235438%S01CR-01improved78
    P-0221837%S01DT-01improved61